biotech news today glp-1 Therapies Reshape Future of Healthcare | Digital Medicine Society (DiMe) posted on the topic The expanding benefits of GLP-1

Addressing root causes: Unlike medications that simply lower blood sugar, weight loss addresses the excess weight that contributed to developing diabetes in the first place

2020;8(1):e001375

Gastrointestinal symptoms developed in 56% of participants in one trial [6]

This change could force the food and beverage industry to adapt by offering smaller portion sizes or more health-focused options

Considering GLP-1 medications for weight loss

World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 (GLP-1) Therapies for the Treatment of Obesity in Adults, recommends long-term GLP-1 therapies combined with intensive behavioural therapy to maximise and sustain benefits